Literature DB >> 20711221

AMPK in cardiovascular health and disease.

Najeeb A Shirwany1, Ming-Hui Zou.   

Abstract

AbstractAdenosine Monophosphate-activated Protein Kinase (AMPK), a serine/threonine kinase and a member of the Snf1/AMPK protein kinase family, consists of three protein subunits that together make a functional enzyme. AMPK, which is expressed in a number of tissues, including the liver, brain, and skeletal muscle, is allosterically activated by a rise in the AMP: ATP ratio (ie in a low ATP or energy depleted state). The net effect of AMPK activation is to halt energy consuming (anabolic) pathways but to promote energy conserving (catabolic) cellular pathways. AMPK has therefore often been dubbed the "metabolic master switch". AMPK also plays a critical physiological role in the cardiovascular system. Increasing evidence suggest that AMPK might also function as a sensor by responding to oxidative stress. Mostly importantly, AMPK modulates endogenous antioxidant gene expression and/or suppress the production of oxidants. AMPK promotes cardiovascular homeostasis by ensuring an optimum redox balance on the heart and vascular tissues. Dysfunctional AMPK is thought to underlie several cardiovascular pathologies. Here we review this kinase from its structure and discovery to current knowledge of its adaptive and maladaptive role in the cardiovascular system.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20711221      PMCID: PMC3078651          DOI: 10.1038/aps.2010.139

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  113 in total

Review 1.  Mechanisms of endothelial dysfunction: clinical significance and preventive non-pharmacological therapeutic strategies.

Authors:  S Taddei; L Ghiadoni; A Virdis; D Versari; A Salvetti
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

2.  Modulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity with cAMP and wth protein fractions of rat liver cytosol.

Authors:  Z H Beg; D W Allmann; D M Gibson
Journal:  Biochem Biophys Res Commun       Date:  1973-10-15       Impact factor: 3.575

3.  Regulation of hepatic acetyl coenzyme A carboxylase by phosphorylation and dephosphorylation.

Authors:  C A Carlson; K H Kim
Journal:  J Biol Chem       Date:  1973-01-10       Impact factor: 5.157

4.  AMPK inhibits fatty acid-induced increases in NF-kappaB transactivation in cultured human umbilical vein endothelial cells.

Authors:  Jose M Cacicedo; Norito Yagihashi; John F Keaney; Neil B Ruderman; Yasuo Ido
Journal:  Biochem Biophys Res Commun       Date:  2004-11-26       Impact factor: 3.575

Review 5.  AMP-activated protein kinase: a core signalling pathway in the heart.

Authors:  A S Kim; E J Miller; L H Young
Journal:  Acta Physiol (Oxf)       Date:  2009-02-23       Impact factor: 6.311

6.  Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis.

Authors:  K A Reimer; C E Murry; I Yamasawa; M L Hill; R B Jennings
Journal:  Am J Physiol       Date:  1986-12

7.  Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis.

Authors:  Anke C Webler; U Ruth Michaelis; Rüdiger Popp; Eduardo Barbosa-Sicard; Andiappan Murugan; John R Falck; Beate Fisslthaler; Ingrid Fleming
Journal:  Am J Physiol Cell Physiol       Date:  2008-09-11       Impact factor: 4.249

8.  AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633.

Authors:  Zhen Chen; I-Chen Peng; Wei Sun; Mei-I Su; Pang-Hung Hsu; Yi Fu; Yi Zhu; Kathryn DeFea; Songqin Pan; Ming-Daw Tsai; John Y-J Shyy
Journal:  Circ Res       Date:  2009-01-08       Impact factor: 17.367

9.  Activation of 5'-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells. Role of peroxynitrite.

Authors:  Ming-Hui Zou; Xiu-Yun Hou; Chao-Mei Shi; Stacy Kirkpatick; Feng Liu; Mitchell H Goldman; Richard A Cohen
Journal:  J Biol Chem       Date:  2003-06-24       Impact factor: 5.157

10.  Upregulation of mitochondrial uncoupling protein-2 by the AMP-activated protein kinase in endothelial cells attenuates oxidative stress in diabetes.

Authors:  Zhonglin Xie; Junhua Zhang; Jiliang Wu; Benoit Viollet; Ming-Hui Zou
Journal:  Diabetes       Date:  2008-10-03       Impact factor: 9.461

View more
  47 in total

1.  AMP-Activated Protein Kinase Alpha 2 Deletion Induces VSMC Phenotypic Switching and Reduces Features of Atherosclerotic Plaque Stability.

Authors:  Ye Ding; Miao Zhang; Wencheng Zhang; Qiulun Lu; Zhejun Cai; Ping Song; Imoh Sunday Okon; Lei Xiao; Ming-Hui Zou
Journal:  Circ Res       Date:  2016-07-20       Impact factor: 17.367

2.  AMP-activated protein kinase inhibits transforming growth factor-β-mediated vascular smooth muscle cell growth: implications for a Smad-3-dependent mechanism.

Authors:  Joshua D Stone; Andrew W Holt; Jackson R Vuncannon; Jeffrey J Brault; David A Tulis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-14       Impact factor: 4.733

3.  Bezafibrate enhances proliferation and differentiation of osteoblastic MC3T3-E1 cells via AMPK and eNOS activation.

Authors:  Xing Zhong; Ling-ling Xiu; Guo-hong Wei; Yuan-yuan Liu; Lei Su; Xiao-pei Cao; Yan-bing Li; Hai-peng Xiao
Journal:  Acta Pharmacol Sin       Date:  2011-04-18       Impact factor: 6.150

4.  PAN-AMPK activator O304 improves glucose homeostasis and microvascular perfusion in mice and type 2 diabetes patients.

Authors:  Pär Steneberg; Emma Lindahl; Ulf Dahl; Emmelie Lidh; Jurate Straseviciene; Fredrik Backlund; Elisabet Kjellkvist; Eva Berggren; Ingela Lundberg; Ingela Bergqvist; Madelene Ericsson; Björn Eriksson; Kajsa Linde; Jacob Westman; Thomas Edlund; Helena Edlund
Journal:  JCI Insight       Date:  2018-06-21

5.  Comprehensive Characterization of AMP-Activated Protein Kinase Catalytic Domain by Top-Down Mass Spectrometry.

Authors:  Deyang Yu; Ying Peng; Serife Ayaz-Guner; Zachery R Gregorich; Ying Ge
Journal:  J Am Soc Mass Spectrom       Date:  2016-02       Impact factor: 3.109

Review 6.  AMP-activated protein kinase, stress responses and cardiovascular diseases.

Authors:  Shaobin Wang; Ping Song; Ming-Hui Zou
Journal:  Clin Sci (Lond)       Date:  2012-06       Impact factor: 6.124

7.  LncRNA SNHG1 regulates vascular endothelial cell proliferation and angiogenesis via miR-196a.

Authors:  Liping Zhang; Qiang Zhang; Lingxia Lv; Zhu Jianhua; Chen Ting; Yutao Wu
Journal:  J Mol Histol       Date:  2020-04-15       Impact factor: 2.611

8.  Lipid metabolism disturbances and AMPK activation in prolonged propofol-sedated rabbits under mechanical ventilation.

Authors:  Wei Jiang; Zheng-bo Yang; Quan-hong Zhou; Xiang Huan; Li Wang
Journal:  Acta Pharmacol Sin       Date:  2011-12-12       Impact factor: 6.150

Review 9.  Pharmacological Strategies to Retard Cardiovascular Aging.

Authors:  Irene Alfaras; Clara Di Germanio; Michel Bernier; Anna Csiszar; Zoltan Ungvari; Edward G Lakatta; Rafael de Cabo
Journal:  Circ Res       Date:  2016-05-13       Impact factor: 17.367

Review 10.  Cereblon in health and disease.

Authors:  Hyoung Kyu Kim; Tae Hee Ko; Bayalagmaa Nyamaa; Sung Ryul Lee; Nari Kim; Kyung Soo Ko; Byoung Doo Rhee; Chul-Seung Park; Bernd Nilius; Jin Han
Journal:  Pflugers Arch       Date:  2016-06-24       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.